E-Mei Advanced Blood Glucose Monitoring System - Taiwan Registration 44f9c5df1db0be9f28fd33f0a3b2e204
Access comprehensive regulatory information for E-Mei Advanced Blood Glucose Monitoring System in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 44f9c5df1db0be9f28fd33f0a3b2e204 and manufactured by BIOPTIK TECHNOLOGY, INC.. The authorized representative in Taiwan is BIOPTIK TECHNOLOGY, INC..
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Device Details
Product Details
This product is for in vitro testing only, using the detection of fresh fingertip microvascular whole blood to quantify blood glucose levels. This product can be used by self-testing and healthcare professionals, but is not intended for testing of newborns.
I General, Plastic Surgery & Dermatology;; A Clinical Chemistry and Clinical Toxicology
I.4800 Manual instruments for general surgery; A.1345 Glucose Test System
ๅ็ข;; QMS/QSD
Dates and Status
May 07, 2019
May 07, 2029